Your browser doesn't support javascript.
loading
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study.
Fagan, Anne M; Henson, Rachel L; Li, Yan; Boerwinkle, Anna H; Xiong, Chengjie; Bateman, Randall J; Goate, Alison; Ances, Beau M; Doran, Eric; Christian, Bradley T; Lai, Florence; Rosas, H Diana; Schupf, Nicole; Krinsky-McHale, Sharon; Silverman, Wayne; Lee, Joseph H; Klunk, William E; Handen, Benjamin L; Allegri, Ricardo F; Chhatwal, Jasmeer P; Day, Gregory S; Graff-Radford, Neill R; Jucker, Mathias; Levin, Johannes; Martins, Ralph N; Masters, Colin L; Mori, Hiroshi; Mummery, Catherine J; Niimi, Yoshiki; Ringman, John M; Salloway, Stephen; Schofield, Peter R; Shoji, Mikio; Lott, Ira T.
Afiliação
  • Fagan AM; Department of Neurology, Washington University School of Medicine, St Louis, MO, USA. Electronic address: fagana@wustl.edu.
  • Henson RL; Department of Neurology, Washington University School of Medicine, St Louis, MO, USA.
  • Li Y; Department of Neurology, Washington University School of Medicine, St Louis, MO, USA.
  • Boerwinkle AH; Department of Neurology, Washington University School of Medicine, St Louis, MO, USA.
  • Xiong C; Division of Biostatistics, Washington University School of Medicine, St Louis, MO, USA.
  • Bateman RJ; Department of Neurology, Washington University School of Medicine, St Louis, MO, USA.
  • Goate A; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ances BM; Department of Neurology, Washington University School of Medicine, St Louis, MO, USA.
  • Doran E; Department of Pediatrics, UC Irvine School of Medicine, Irvine, CA, USA.
  • Christian BT; Department of Medical Physics, Waisman Center, University of Wisconsin-Madison, Madison, WI, USA; Department of Psychiatry, Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.
  • Lai F; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • Rosas HD; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • Schupf N; Department of Epidemiology, Columbia University Irving Medical Center, New York, NY, USA; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
  • Krinsky-McHale S; New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA.
  • Silverman W; Department of Pediatrics, UC Irvine School of Medicine, Irvine, CA, USA.
  • Lee JH; Department of Epidemiology, Columbia University Irving Medical Center, New York, NY, USA; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
  • Klunk WE; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
  • Handen BL; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
  • Allegri RF; Department of Cognitive Neurology, Instituto Neurologico Fleni, Buenos Aires, Argentina.
  • Chhatwal JP; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
  • Day GS; Department of Neurology, Mayo Clinic Florida, Jacksonville, FL, USA.
  • Graff-Radford NR; Department of Neurology, Mayo Clinic Florida, Jacksonville, FL, USA.
  • Jucker M; Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases, Tübingen, Germany.
  • Levin J; Department of Neurology, Ludwig-Maximilians-Universität München, German Center for Neurodegenerative Diseases, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Martins RN; School of Medical Health and Sciences, Edith Cowan University, Joondalup, WA, Australia.
  • Masters CL; Florey Institute, Melbourne, VIC, Australia; University of Melbourne, Melbourne, VIC, Australia.
  • Mori H; Department of Clinical Neuroscience, Osaka City University Medical School, Abenoku, Osaka, Japan.
  • Mummery CJ; Dementia Research Centre, Institute of Neurology, University College London, London, UK.
  • Niimi Y; Unit for Early and Exploratory Clinical Development, University of Tokyo, Tokyo, Japan.
  • Ringman JM; Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Salloway S; Memory and Aging Program, Brown University, Butler Hospital, Providence, RI, USA.
  • Schofield PR; Neuroscience Research Australia, School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
  • Shoji M; Geriatrics Research Institute and Hospital, Maebashi, Gunma, Japan.
  • Lott IT; Department of Pediatrics, UC Irvine School of Medicine, Irvine, CA, USA.
Lancet Neurol ; 20(8): 615-626, 2021 08.
Article em En | MEDLINE | ID: mdl-34302786
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Down / Doença de Alzheimer Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Neurol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Down / Doença de Alzheimer Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Neurol Ano de publicação: 2021 Tipo de documento: Article